Regimen of administration for 5-(2-chlorophenyl)-1 ,2-dihydro-7-fluoro-8-methoxy-3-methylpyrazolo (3, 4.-b) (1, 4) benzodiazepine

Details for Australian Patent Application No. 2006301292 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Mikulski, Stanislaw M.

Agent Davies Collison Cave

Pub. Number AU-A-2006301292

PCT Pub. Number WO2007/042430

Priority 60/727,020 14.10.05 US

Filing date 3 October 2006

Wipo publication date 19 April 2007

International Classifications

A61K 31/5517 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/042430 Priority application(s): WO2007/042430

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006301300-Encapsulated luminescent pigments

2006301280-Process for the production of arachidonic acid and/or eicosapentaenoic acid